Wijsenbeek MS - Search Results

1

Inflammation and immunity in IPF pathogenesis and treatment.

Heukels P, Moor CC, von der Thüsen JH, Wijsenbeek MS, Kool M. Heukels P, et al. Among authors: wijsenbeek ms. Respir Med. 2019 Feb;147:79-91. doi: 10.1016/j.rmed.2018.12.015. Epub 2019 Jan 9. Respir Med. 2019. PMID: 30704705 Free article. Review.

2

Early Experience of Pirfenidone in Daily Clinical Practice in Belgium and The Netherlands: a Retrospective Cohort Analysis.

Wijsenbeek MS, Grutters JC, Wuyts WA. Wijsenbeek MS, et al. Adv Ther. 2015 Jul;32(7):691-704. doi: 10.1007/s12325-015-0225-1. Epub 2015 Jul 15. Adv Ther. 2015. PMID: 26173796 Free PMC article.

3

European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers.

Bonella F, Wijsenbeek M, Molina-Molina M, Duck A, Mele R, Geissler K, Wuyts W. Bonella F, et al. Eur Respir J. 2016 Feb;47(2):597-606. doi: 10.1183/13993003.01204-2015. Epub 2015 Nov 19. Eur Respir J. 2016. PMID: 26585424 Free article.

4

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives.

Kreuter M, Bonella F, Wijsenbeek M, Maher TM, Spagnolo P. Kreuter M, et al. Biomed Res Int. 2015;2015:329481. doi: 10.1155/2015/329481. Epub 2015 Dec 8. Biomed Res Int. 2015. PMID: 26779535 Free PMC article. Review.

5

Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy.

van den Blink B, Dillingh MR, Ginns LC, Morrison LD, Moerland M, Wijsenbeek M, Trehu EG, Bartholmai BJ, Burggraaf J. van den Blink B, et al. Eur Respir J. 2016 Mar;47(3):889-97. doi: 10.1183/13993003.00850-2015. Epub 2016 Feb 11. Eur Respir J. 2016. PMID: 26869678 Free article. Clinical Trial.

6

Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.

Kreuter M, Wijsenbeek MS, Vasakova M, Spagnolo P, Kolb M, Costabel U, Weycker D, Kirchgaessler KU, Maher TM. Kreuter M, et al. Among authors: wijsenbeek ms. Eur Respir J. 2016 Jun;47(6):1776-84. doi: 10.1183/13993003.02087-2015. Epub 2016 Apr 21. Eur Respir J. 2016. PMID: 27103382 Free article. Clinical Trial.

7

Acetylcysteine in IPF: the knockout blow?

Wijsenbeek MS, Collard HR. Wijsenbeek MS, et al. Lancet Respir Med. 2016 Jun;4(6):420-1. doi: 10.1016/S2213-2600(16)30085-6. Epub 2016 May 5. Lancet Respir Med. 2016. PMID: 27161256 No abstract available.

8

Medical Therapy in Idiopathic Pulmonary Fibrosis.

Antoniou KM, Wuyts W, Wijsenbeek M, Wells AU. Antoniou KM, et al. Semin Respir Crit Care Med. 2016 Jun;37(3):368-77. doi: 10.1055/s-0036-1582010. Epub 2016 May 27. Semin Respir Crit Care Med. 2016. PMID: 27231861 Review.

9

European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity.

Bonella F, Wijsenbeek M, Molina-Molina M, Duck A, Mele R, Geissler K, Wuyts W. Bonella F, et al. Eur Respir J. 2016 Jul;48(1):283-4. doi: 10.1183/13993003.00604-2016. Eur Respir J. 2016. PMID: 27365516 Free article. No abstract available.

10

Cough in idiopathic pulmonary fibrosis.

van Manen MJ, Birring SS, Vancheri C, Cottin V, Renzoni EA, Russell AM, Wijsenbeek MS. van Manen MJ, et al. Among authors: wijsenbeek ms. Eur Respir Rev. 2016 Sep;25(141):278-86. doi: 10.1183/16000617.0090-2015. Eur Respir Rev. 2016. PMID: 27581827 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters